Stockreport

Medicenna Presenting at Next-Gen Cytokine Therapeutics Summit

Medicenna Therapeutics Corp. - Common Shares  (MDNA) 
PDF TORONTO and HOUSTON, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (NASDAQ: MDNA TSX: MDNA), a clinical stage immuno-o [Read more]